Polypharmacy and weak body metabolism puts elderly patients at a high risk of adverse clinical outcomes. Several patients of this age-group require “deprescription” of drugs that are potentially inappropriate for them. In the case of cardiac diseases, there is no point in prescribing or continuing statins for severely frail elderly patients owing to the low efficacy of these drugs in them.
If statins are to be prescribed, lower doses are more appropriate, given their potentially strong side-effects in the elderly. Take this quiz to refresh your knowledge on the role of physicians in deciding therapy for frail elderly patients.